Tourmaline Bio price target raised to $43 from $42 at Wedbush
Wedbush raised the firm’s price target on Tourmaline Bio (TRML) to $43 from $42 and keeps an Outperform rating on the shares. All key ...
Tourmaline Oil Corp. stock falls Thursday, underperforms market
Tourmaline Oil Corp. closed 7.6% below its 52-week high of C$70.83, which the company reached on February 21st.
Tourmaline Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
Phase 2 TRANQUILITY trial in patients with elevated high-sensitivity C-reactive protein and chronic kidney disease over-enrolled to 143 total ...
HC Wainwright Issues Positive Forecast for Tourmaline Bio (NASDAQ:TRML) Stock Price
Tourmaline Bio (NASDAQ:TRML – Get Free Report) had its price objective lifted by analysts at HC Wainwright from $49.00 to $50.00 in a research report issued on Friday,Benzinga reports. The firm ...
Tourmaline Oil Corp. stock rises Wednesday, outperforms market
Tourmaline Oil Corp. closed 6.2% below its 52-week high of C$70.83, which the company achieved on February 21st.
Nasdaq4d
TOURMALINE BIO Earnings Results: $TRML Reports Quarterly Earnings
TOURMALINE BIO ($TRML) posted quarterly earnings results on Thursday, March 13th. The company reported earnings of -$0.86 per share, beating estimates of -$0.89 by $0 ...
Just Three Days Till Tourmaline Oil Corp. (TSE:TOU) Will Be Trading Ex-Dividend
Readers hoping to buy Tourmaline Oil Corp. ( TSE:TOU ) for its dividend will need to make their move shortly, as ...
Wedbush Predicts Tourmaline Bio FY2024 Earnings
Analysts at Wedbush issued their FY2024 EPS estimates for shares of Tourmaline Bio in a research note issued on Thursday, March 6th. Wedbush analyst L. Chico expects that the company will post ...
Revenue Miss: Tourmaline Oil Corp. Fell 12% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Last week, you might have seen that Tourmaline Oil Corp. ( TSE:TOU ) released its full-year result to the market.